Angiogenesis pp 233-238 | Cite as

Chronic Cellular Injury and Human Proliferative Disorders

  • Harry N. Antoniades
Part of the NATO ASI Series book series (NSSA, volume 263)


Carcinogenesis and normal tissue regeneration share some common characteristics. In both states there is an active cellular proliferation and induction of the expression of potent mitogenic growth factors and receptors that promote the proliferative activity. Normal tissue regeneration is initiated by acute injury. Carcinogenesis is linked to prolonged chronic cellular injury by a variety of toxic agents including carcinogen. The major difference between the two processes is that in normal tissue repair, both cellular proliferation and growth factor expression are suppressed upon the healing of the wound. In contrast, in cancer and in some nonmalignant proliferative disorders cellular proliferation remains uncontrolled, and the expression of the mitogenic growth factors and receptors remains unsuppressed. It seems that in these disorders, the pathologic lesion is not the induction of growth factor and cytokine expression. Induction of these factors in response to acute or chronic injury appears to be a physiologic process aiming at the repair of the damage caused by the injury. What is abnormal in these pathologic states is a malfunction of the reversal mechanisms that normally control the suppression of the genes encoding for these growth factors and cytokines.


Idiopathic Pulmonary Fibrosis Chronic Injury Acute Injury Growth Factor Expression Transform Growth Factor Alpha 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    H.N. Antoniades, Linking cellular injury to gene expression and human proliferative disorders: examples with the PDGF genes, Mol. Carcinog. 6: 175 (1992).PubMedCrossRefGoogle Scholar
  2. 2.
    H.N. Antoniades, T. Galanopoulos, J. Neville-Golden, C.P. Kiritsy, and S.E. Lynch, Injury induces in vivo expression of PDGF and PDGF-receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts, Proc. Natl. Acad. Sci. USA. 88: 565 (1991).PubMedCrossRefGoogle Scholar
  3. 3.
    H.N. Antoniades, T. Galanopoulos, J. Neville-Golden, C.P. Kiritsy, and S.E. Lynch, Expression of growth factor and receptor mRNAs in skin epithelial cells following acute cutaneous injury, Am. J. Pathol. 142: 1099 (1993).PubMedGoogle Scholar
  4. 4.
    H.-A. Hansson, E. Jennische, and A. Skottner, Regenerating endothelial cell express insulin-like growth factor I immunoreactivity after arterial injury, Cell Tissue Res. 250: 499 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    G.R. Grotendorst, C.A. Grotendorst, and T. Gilman, Production of growth factors (PDGF an TGF-beta) at the site of tissue repair, Prog. Clin. Biol. Res. 266: 47 (1988).PubMedGoogle Scholar
  6. 6.
    G.R. Grotendorst, Y. Soma, K. Takehara, and M. Charette, EGF and TGF-alpha are potent chemoattractants for endothelial cells and EGF-like peptides are present at sites of tissue regeneration. J. Cell Physiol. 139: 617 (1989).PubMedCrossRefGoogle Scholar
  7. 7.
    H. Steefnos, C. Lossing, and H.A. Hansson, Immunohistochemical demonstration of endogenous growth factors in wound healing, Wounds 2: 218 (1990).Google Scholar
  8. 8.
    C.J.M. Kane, P.C. Hanawait, A.M. Knapp, and J.N. Mansbridge, Transforming growth factor-ßl localization normal and psoriatic epidermal keratinocytes in situ, J. Cell Physiol. 144: 144 (1990).PubMedCrossRefGoogle Scholar
  9. 9.
    D.J. Whitby, and M.W. Ferguson, Immunohistochemical localization of growth factors in fetal wound healing, Dev. Biol. 147: 207 (1991).PubMedCrossRefGoogle Scholar
  10. 10.
    S. Werner, K.G. Peters, M.T. Longaker, F. Fuller-Pace, M.J. Bander, and L.T. Williams, Large induction of keratinocyte growth factor expression in the dermis during wound healing, Proc. Natl. Acad. Sci. USA. 89: 6896, 1992.PubMedCrossRefGoogle Scholar
  11. 11.
    S.E. Lynch, R.B. Colvin, and H.N. Antoniades, Growth factors in wound healing: single and synergistic effects on partial thickness porcine skin wounds, J. Clin. Invest. 84: 640 (1989).PubMedCrossRefGoogle Scholar
  12. 12.
    B. Vogelstein, and K.W. Kinzler, p53 function and dysfunction, Cell 70: 523 (1992).PubMedCrossRefGoogle Scholar
  13. 13.
    S.J. Ullrich, C.W. Anderson, W.E. Mercer, and E. Appella, The p53 tumor suppressor protein, a modulator of cell proliferation, J. Biol. Chem. 267: 15259 (1992).PubMedGoogle Scholar
  14. 14.
    G.P. Zambetti, and A.J. Levine, A comparison of the biological activities of wild-type and mutant p53, FASEB J. 7: 855 (1993).PubMedGoogle Scholar
  15. 15.
    H.N. Antoniades, M.A. Bravo, R.E. Avila, T. Galanopoulos, J. Neville-Golden, M. Maxwell, and M. Selman, Platelet-derived growth factor in idiopathic pulmonary fibrosis, J. Clin. Invest. 86: 1055 (1990).PubMedCrossRefGoogle Scholar
  16. 16.
    H.N. Antoniades, T. Galanopoulos, J. Neville-Golden, and C.J. O’Hara, Malignant epithelial cells in primary human lung carcinomas co-express in vivo platelet-derived growth factor (PDGF) and PDGF receptor mRNAs and their protein products, Proc. Natl. Acad. Sci. USA. 89: 3942 (1992).PubMedCrossRefGoogle Scholar
  17. 17.
    C.C. Chung, and H.N. Antoniades, Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor a messenger RNAs and their respective receptor messenger RNAs in primary gastric carcinomas: In vivo studies with in situ hybridization and immunocytochemistry, Cancer Res. 52: 3453 (1992).PubMedGoogle Scholar
  18. 18.
    M. Xiao, T. Galanopoulos, J. Neville-Golden, J.P. Richie, and H.N. Antoniades, Human prostate adenocarcinomas express in vivo mRNA and protein products for platelet-derived growth factor B and its receptor, Int. J. Oncol. in press.Google Scholar
  19. 19.
    P. McL Black, Brain tumors, N. Eng. J. Med. 324: 1471 (1991).CrossRefGoogle Scholar
  20. 20.
    S.K. Clinton, and P. Libby, Cytokines and growth factors in atherogenesis, Arch. Pathol. Lab. Med. 116: 1292 (1992).PubMedGoogle Scholar
  21. 21.
    R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362: 801 (1993).PubMedCrossRefGoogle Scholar
  22. 22.
    H.F. Dvorak, Tumors: wounds that do not heal, N. Eng. J. Med. 315: 1650 (1986).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Harry N. Antoniades
    • 1
  1. 1.The Center for Blood Research and the Department of Cancer Biology and NutritionHarvard School of Public HealthBostonUSA

Personalised recommendations